Experts back faecal transplant for two conditions
Australia's first clinical guidance on the therapy sets out the evidence for its use
Faecal microbiota transplantation (FMT) is indicated for certain patients with C. difficile infection and for ulcerative colitis, according to the first Australian expert consensus statements on the treatment.
FMT is recommended for recurrent or refractory C. difficile infection, although antibiotics should remain first-line therapy for an initial episode, according to the working group of gastroenterologists, surgeons, clinical microbiologists and infectious diseases specialists.
